risperidone has been researched along with Parasitic Skin Diseases in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laidler, N | 1 |
Healy, R | 1 |
Taylor, R | 1 |
Dhoat, S | 1 |
Leschynska, E | 1 |
Bewley, AP | 1 |
Situm, M | 1 |
Dediol, I | 1 |
Buljan, M | 1 |
Živković, MV | 1 |
Buljan, D | 1 |
Lepping, P | 1 |
Freudenmann, RW | 1 |
3 reviews available for risperidone and Parasitic Skin Diseases
Article | Year |
---|---|
Delusions of parasitosis: a brief review of the literature and pathway for diagnosis and treatment.
Topics: Antipsychotic Agents; Benzodiazepines; Delusions; Humans; Olanzapine; Risperidone; Skin Diseases, Pa | 2018 |
Delusion of parasitosis: case report and current concept of management.
Topics: Antipsychotic Agents; Delusions; Female; Humans; Middle Aged; Phobic Disorders; Prognosis; Recurrenc | 2011 |
Delusional parasitosis: a new pathway for diagnosis and treatment.
Topics: Antipsychotic Agents; Delusions; Dose-Response Relationship, Drug; Female; Humans; Male; Physician-P | 2008 |
1 other study available for risperidone and Parasitic Skin Diseases
Article | Year |
---|---|
Management of patients with delusional parasitosis in a joint dermatology/ liaison psychiatry clinic.
Topics: Adult; Aged; Ambulatory Care Facilities; Antipsychotic Agents; Delusions; Dermatology; Female; Human | 2009 |